Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin 5 mg vs atorvastatin 10 mg in UK Asian subjects with primary hypercholesterolaemia
2006-003286-14Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in primary hypercholesterolaemia comparing Rosuvastatin 5 mg with Atorvastatin 10 mg (2 arms). Started Jul 2006; status: terminated.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
primary hypercholesterolaemia
Beyond the preview
Go deeper on 2006-003286-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003286-14.